A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...
Investigators from HSS and collaborating centers identified distinct immune cell patterns in blood that signal an increased risk of developing rheumatoid arthritis (RA) before symptoms occur. The ...
Physicians are learning how to better support the needs of people with rheumatoid arthritis (RA) from online search trends, according to a new study from researchers at Hospital for Special Surgery ...